Metropolitan Life Insurance Co NY Sells 1,677 Shares of Oracle Co. (NYSE:ORCL)

Metropolitan Life Insurance Co NY reduced its stake in Oracle Co. (NYSE:ORCL) by 2.4% during the second quarter, Holdings Channel.com reports. The fund owned 67,063 shares of the enterprise software provider’s stock after selling 1,677 shares during the quarter. Metropolitan Life Insurance Co NY’s holdings in Oracle were worth $7,987,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in ORCL. Fairfield Bush & CO. boosted its stake in shares of Oracle by 3.1% during the first quarter. Fairfield Bush & CO. now owns 73,791 shares of the enterprise software provider’s stock valued at $6,105,000 after purchasing an additional 2,221 shares in the last quarter. AMI Investment Management Inc. boosted its position in Oracle by 2.9% during the 1st quarter. AMI Investment Management Inc. now owns 20,467 shares of the enterprise software provider’s stock valued at $1,693,000 after acquiring an additional 579 shares in the last quarter. Baird Financial Group Inc. boosted its position in Oracle by 29.2% during the 1st quarter. Baird Financial Group Inc. now owns 588,460 shares of the enterprise software provider’s stock valued at $48,686,000 after acquiring an additional 132,920 shares in the last quarter. Zions Bancorporation N.A. boosted its position in Oracle by 79.6% during the 1st quarter. Zions Bancorporation N.A. now owns 6,854 shares of the enterprise software provider’s stock valued at $567,000 after acquiring an additional 3,038 shares in the last quarter. Finally, Covestor Ltd boosted its position in Oracle by 125.2% during the first quarter. Covestor Ltd now owns 1,995 shares of the enterprise software provider’s stock valued at $165,000 after purchasing an additional 1,109 shares in the last quarter. 42.44% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Oracle

In other Oracle news, Director George H. Conrades sold 2,325 shares of the firm’s stock in a transaction on Monday, November 13th. The stock was sold at an average price of $113.76, for a total value of $264,492.00. Following the completion of the sale, the director now directly owns 17,836 shares of the company’s stock, valued at approximately $2,029,023.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 42.80% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on ORCL shares. Mizuho reaffirmed a “buy” rating and set a $150.00 price objective on shares of Oracle in a research report on Tuesday, September 19th. Berenberg Bank raised their target price on shares of Oracle from $82.50 to $110.00 and gave the company a “hold” rating in a research note on Thursday, September 21st. Jefferies Financial Group upped their price target on Oracle from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Thursday, September 7th. HSBC started coverage on Oracle in a research report on Friday, September 15th. They issued a “buy” rating and a $144.00 price objective for the company. Finally, UBS Group reduced their target price on Oracle from $140.00 to $135.00 and set a “buy” rating on the stock in a research report on Tuesday, September 12th. Eleven analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, Oracle has an average rating of “Moderate Buy” and a consensus target price of $124.23.

Oracle Stock Up 0.3 %

ORCL opened at $115.74 on Monday. Oracle Co. has a twelve month low of $78.06 and a twelve month high of $127.54. The company has a quick ratio of 0.87, a current ratio of 0.87 and a debt-to-equity ratio of 29.72. The company has a 50-day moving average price of $108.95 and a 200 day moving average price of $111.75. The company has a market cap of $317.06 billion, a PE ratio of 34.33, a price-to-earnings-growth ratio of 2.92 and a beta of 1.03.

Oracle (NYSE:ORCL) last posted its quarterly earnings data on Monday, September 11th. The enterprise software provider reported $1.19 EPS for the quarter, beating the consensus estimate of $1.15 by $0.04. The firm had revenue of $12.45 billion during the quarter, compared to the consensus estimate of $12.48 billion. Oracle had a negative return on equity of 3,631.39% and a net margin of 18.40%. The firm’s revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.81 EPS. Sell-side analysts expect that Oracle Co. will post 4.48 earnings per share for the current fiscal year.

Oracle Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 26th. Shareholders of record on Thursday, October 12th were issued a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, October 11th. This represents a $1.60 dividend on an annualized basis and a yield of 1.38%. Oracle’s payout ratio is 47.62%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.